Correction of erectile dysfunction in patients undergoing radical prostatectomy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Radical prostatectomy (RPE) is a widespread surgery in the world performed in patients with localized prostate cancer. Despite the widespread introduction of nerve-sparing radical prostatectomy techniques, erectile dysfunction after radical prostatectomy occurs very frequently, which seriously affect the quality of life of patients. At the present stage of development of medicine, differentiated approach to each patient is required. "Patient’s expectation management" is an important prerequisite for successful sexual rehabilitation. The use of conventional methods for correction of erectile dysfunction after radical prostatectomy has its own characteristics. Currently, phosphodiesterase type 5 inhibitors, however, are still first-line agents for the recovery of erectile function. Their combined use with other methods has encouraging results.

Full Text

Restricted Access

About the authors

S. O Yudovsky

MSMSU n.a. A.I. Evdokimov

Email: yudovskys@gmail.com
Department of Urology PhD in Medical Sciences, urologist

D. Yu Pushkar

MSMSU n.a. A.I. Evdokimov

Department of Urology

References

  1. Salonia A., Burnett A.L., Graefen M. et al. Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery. Eur. Urol. 2012;62(2):261-272.
  2. Salonia A., Burnett A.L., Graefen M. et al. Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur. Urol. 2012;62(2):273-286.
  3. Sanda M.G., Dunn R.L., Michalski J. et al. Quality of life and satisfaction with outcome among prostatecancer survivors. N. Engl. J. Med 2008;358(12):1250-1261.
  4. Велиев Е.И., Лоран О.Б. Лечение эректильной дисфункции после нервосберегающей радикальной позадилонной простатэктомии. Урология. 2006;1:28-33.
  5. Велиев Е.И., Ванин А.Ф., Котов С.В., Шишло В.К. Современные аспекты патофизиологии и профилактики эректильной дисфункции и кавернозного фиброза после радикальной простатэктомии. Урология. 2009;46-51.
  6. Живов А.В., Плеханов А.Ю. Кавернозный фиброз и эректильная функция. Андрология и генитальная хирургия. 2004;4:36-41.
  7. Ficarra V., Novara G., Ahlering T.E. et al. Systematic review and metaanalysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur. Urol. 2012;62(3):418-430.
  8. Hatzimouratidis K., Burnett A.L., Hatzichristou D. et al. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur. Urol. 2009;55:334-347.
  9. Magheli A., Burnett A.L. Erectile dysfunction following prostatectomy: prevention and treatment. Nat. Rev. Urol 2009;6(8):415-427.
  10. Ferronha F., Barros F., Vaz Santos V. et al. Is there any evidence of superiority between retropubic, laparoscopic or robot-assisted radical prostatectomy? International Braz. J Urol. 2011;37(2):146-160.
  11. Barry M.J., Gallagher P.M., Skinner J.S., et al. Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin. Oncol. 2012;30(5):513-518.
  12. Vickers A., Savage C., Bianco F. et al. Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center. Eur. Urol. 2011 ;59(3):317-322.
  13. Камалов А.А., Хомерики Г.Г., Ефремов Е.А., Ромих В.В., Егоров А.А., Охоботов Д.А. Качество жизни больных после радикальной простатэктомии. Урология. 2005;4:27-29.
  14. Котов С.В. Профилактика кавернозного фиброза после нервосберегающей радикальной простатэктомии: диссертация на соискание ученой степени кандидата медицинских наук. РМАПО. 2009. 105 с.
  15. Мазо Е.Б., Гамидов С.И., Овчинников Р.И., Иремашвили В.В. Новые аспекты патогенеза, профилактики и лечения эректильной дисфункции у больных после радикальной простатэктомии. Consilium Medicum. 2004;6(7).
  16. Mulhall J.P., Slovick R., Hotaling J. et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol. 2002; 167(3): 1371-1375.
  17. Secin F.P., Touijer K., Mulhall J. et al. Anatomy and preservation of accessory pudendal arteries in laparoscopic radical prostatectomy. Eur. Urol. 2007;51(5):1229-1235.
  18. Padma-Nathan H., McCullough A., Guiliano F. et al. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol. 2003; 169:375.
  19. McCullough A., Woo K., Telegraf S., Lepor H. Is sildenafil failure in men after radical retropubic prostatectomy (RRP) due to arterial disease? Penile duplex Doppler findings in 174 men after RRP. Int. J Impot. Res. 2002;14:462-465.
  20. Hong E.K., Lepor H., McCullough A.R. Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nervesparing radical retropubic prostatectomy (RRP). Int. J Impot Res. 1999;1:S15-S22.
  21. Jamal J.E., Engel J.D Management of post-prostatectomy erectile dysfunction. Can J Urol. 2011; 18(3):5726-5730.
  22. Walsh P. C. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. J Urol. 2000; 164:242.
  23. Ayyathurai R., Manoharan M., Nieder A.M. et al. Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. BJU Int. 2008; 101(7):833-836.
  24. Hollenbeck B.K., Dunn R.L., Wei J.T. et al. Determinants of longterm sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol. 2003; 169(4):1453-1457.
  25. Schwartz E.J., Wong P., Graydon R.J. Sildenafil preserves intracorporeal smooth muscle after radicalretropubis prostatectomy. J Urol. 2004; 171(2 Pt 4):771-774.
  26. Bannowsky A., Schulze H., van der Horst C. et al. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 2008;101(10):1279-1283.
  27. Raina R., Lakin M.M., Agarwal A. et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology. 2004;63(5):960-966.
  28. McCullough A.R., Levine L.A., Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med. 2008;5(2):476-484.
  29. Montorsi F., Nathan H.P., McCullough A. et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol. 2004; 172(3): 1036-1041.
  30. Nehra A., Grantmyre J., Nadel A. et al. Vardenafil improved patient satisfaction with erectile hardness,orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J UroI. 2005; 173(6):2067-2071.
  31. Montorsi F., Brock G., Lee J. et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur. Urol. 2008;54(4):924-931.
  32. Montorsi F. et al. Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study. Eur Urol (2013).
  33. Nehra A., Blute M.L., Barrett D.M. et al. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int. J Impot. Res. 2002; 14(Suppl. 1):S38-S42.
  34. Levine L.A., Dimitriou R.J. Vacuum constriction and external erection devices in erectile dysfunction. Urol. Clin. North Am. 2001; 28(2):335-341.
  35. Cookson M.S., Nadig P.W. Long-term results with vacuum constriction device. J Urol. 1993; 149(2):290-294.
  36. Mulhall J.P., Bella A.J., Briganti A. et al. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med. 2010; 7(4 Pt 2):1687-1698.
  37. Pace G., Del Rosso A., Vicentini C. Penile rehabilitation therapy following radical prostatectomy. Disabil. Rehabil. 2010;32(14):1204-1208.
  38. Megas G., Papadopoulos G., Stathouros G., Moschonas D., Gkialas I., Ntoumas K. Urology Department, General Hospital of Athens G. Gennimatas, Athens, Greece Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor Tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction. BJU Int. 2013;112(2):E169-176.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies